คำอธิบาย
Methylprednisolone inhibits CYP3A4-mediated cyclosporine metabolism, raising cyclosporine levels; conversely, cyclosporine may increase methylprednisolone exposure — a bidirectional pharmacokinetic interaction.
กลไก
High-dose methylprednisolone (pulse therapy) can inhibit CYP3A4, reducing cyclosporine clearance and raising trough levels; cyclosporine itself inhibits P-gp and CYP3A4, potentially increasing methylprednisolone exposure. The net direction of the interaction depends on relative doses.
ความสำคัญทางคลินิก
Transplant cases document cyclosporine toxicity (nephrotoxicity, neurotoxicity) following methylprednisolone pulses for acute rejection; cyclosporine troughs may rise by 20–40%.
การจัดการ
Monitor cyclosporine trough levels during and after methylprednisolone pulse therapy; adjust cyclosporine dose as needed; monitor renal function closely.
ข้อจำกัดความรับผิดชอบทางการแพทย์
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.